Status:
COMPLETED
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Multiple Sclerosis
Radiologically Isolated Syndrome
Eligibility:
All Genders
Brief Summary
To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients have given their free consent for use of their samples in research
- Patients have at least 2 years of clinical and radiological follow-up data available Exclusion criterion
- No follow-up of patients
Exclusion
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03357887
Start Date
July 1 2018
End Date
December 31 2018
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nimes
Nîmes, France, 30029